跳至主要内容
临床试验/NCT07271420
NCT07271420招募中4 期

Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年1月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
招募中
入组人数
40
试验地点
1
主要终点
Change in systolic and diastolic blood pressure

研究概览

简要总结

To evaluate the blood pressure lowering effects of thiazide diuretics in patients on peritoneal dialysis

详细描述

This prospective, single-center treatment-withdrawal crossover study enrolled 10 patients on chronic peritoneal dialysis (PD) and uncontrolled hypertension (SBP >140 mmHg and/or DBP >90 mmHg).

Following written informed consent, participants entered the treatment arm, receiving oral hydrochlorothiazide once daily on top of their standard of treatment for 90 days. This was followed by a 14-day washout period, after which participants entered a 90-day control period.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients on chronic peritoneal dialysis, with uncontrolled hypertension (SBP >140 mmHg and/or DBP >90 mmHg)

排除标准

  • Patients with a life expectancy of less than 3 months, planned conversion to hemodialysis, or scheduled kidney transplantation within 3 months

研究组 & 干预措施

Thiazides treatment arm

Active Comparator

干预措施: Hydrochlorothiazide 25mg once per day (Drug)

结局指标

主要结局

Change in systolic and diastolic blood pressure

时间窗: 90 days

次要结局

  • Changes in body composition measured by bio impedance spectroscopy(90 days)
  • Changes in body weight(90 days)
  • Change in urinary fractional excretion of sodium(90 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chan Chun Kau Gordon

Dr

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验